SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-039503
Filing Date
2020-08-12
Accepted
2020-08-12 08:43:42
Documents
53
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q eq-10q_20200630.htm 10-Q 2007408
2 EX-10.1 eq-ex101_26.htm EX-10.1 19867
3 EX-31.1 eq-ex311_6.htm EX-31.1 15886
4 EX-31.2 eq-ex312_7.htm EX-31.2 15973
5 EX-32.1 eq-ex321_8.htm EX-32.1 7276
  Complete submission text file 0001564590-20-039503.txt   6092226

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT eq-20200630.xml EX-101.INS 1189478
7 XBRL TAXONOMY EXTENSION SCHEMA eq-20200630.xsd EX-101.SCH 41333
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eq-20200630_cal.xml EX-101.CAL 42315
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eq-20200630_def.xml EX-101.DEF 163991
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE eq-20200630_lab.xml EX-101.LAB 329952
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eq-20200630_pre.xml EX-101.PRE 256891
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Filer) CIK: 0001746466 (see all company filings)

IRS No.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38692 | Film No.: 201094242
SIC: 2834 Pharmaceutical Preparations